UroGen, Wave each raise $150M follow-ons

UroGen Pharma Ltd. (NASDAQ:URGN) and Wave Life Sciences Ltd. (NASDAQ:WVE) each raised $150 million in follow-ons.

Uro-oncology company UroGen sold 3.7 million shares at $41. The price is a 24% discount to the

Read the full 328 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE